Manufacturing

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Articles

The UK's Medicines and Healthcare products Regulatory Agency has launched a new anticounterfeiting strategy with the aim of curbing the occurrence of falsified medicines in the county's supply chain.

Anticounterfeiting Strategy Launched in UK

Angie Drakulich was editorial director of Pharmaceutical Technology.

Apple's experience with manufacturing facilities in China present opportunity for future best practice.

Some Supply Chain Lessons Can Go a Long Way towards Success

Once again, Apple is doing something the rest of the world should be paying attention to, only this time it's about the company's approach to managing the global supply chain-even when things go wrong.

Supply Chain Lessons

Amy Ritter was Scientific Editor, BioPharm International.

With around 80% of APIs manufactured outside the US, many in developing nations without strong regulatory oversight.

Pooling Resources to Strengthen Supply-Chain Security

“One of the most daunting challenges facing pharmaceutical companies is securing the long and complex supply chains that are typical in today’s global industry.

USP Promotes Supply Chain Integrity, Seeks Industry Input

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

Securing the Pharma Supply Chain

Nathan Jessop is a columnist for Pharmaceutical Technology Europe.

Traditionally more prevalent in less industrialised regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries.

Stepping Up the Fight Against Counterfeits

As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.

Expanding Capabilities in the Pharmaceutical Cold Chain

Amy Ritter is Scientific Editor, BioPharm International and Pharmaceutical Technology. Amy Ritter joined the editorial staff of BioPharm International and Pharmaceutical Technology in 2011. She received her BA in Biology from Boston University, and holds a PhD in Neurobiology from SUNY at Stony Brook. Before joining Advanstar’s Pharm Sciences group, she worked in the preclinical pharmacology group at Merck Research Labs, and is the author of numerous peer-reviewed scientific publications.

The US Pharmacopeia announced a draft standard containing best practices for ensuring that drugs can be traced to their original manufacturer, are not counterfeited or adulterated, and can be transported to their intended destination without compromising quality.